Kaposi's Sarcoma
Also known as: Kaposi Sarcoma (KS) / Kaposi's sarcomas / Kaposi Sarcoma / Sarcoma, Kaposi / Kaposi's sarcoma, unspecified / Kaposi sarcoma (morphologic abnormality) / Kaposi's sarcoma (disorder) / Multiple idiopathic hemorrhagic sarcoma / Multiple idiopathic haemorrhagic sarcoma / Kaposi's sarcoma NOS / Multiple haemorrhagic sarcoma / Multiple hemorrhagic sarcoma / Kaposi's sarcoma epidemic type / Kaposi's sarcoma AIDS related / Kaposi's sarcoma with acquired immunodeficiency syndrome (disorder)
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB00034 | Interferon alfa-2a | A form of recombinant human interferon used to stimulate the innate antiviral response in the treatment of hepatitis B and C viruses. |
| DB00105 | Interferon alfa-2b | A form of recombinant human interferon used to treat hepatitis B and C infection, genital warts, hairy cell leukemia, follicular lymphoma, malignant melanoma, and AIDs-related Kaposi's sarcoma. |
| DB01229 | Paclitaxel | A taxoid chemotherapeutic agent used as first-line and subsequent therapy for the treatment of advanced carcinoma of the ovary, and other various cancers including breast and lung cancer. |
| DB08910 | Pomalidomide | A thalidomide analogue used in combination with dexamethasone to treat patients with multiple myeloma. |
| DB00570 | Vinblastine | A vinca alkaloid used to treat breast cancer, testicular cancer, neuroblastoma, Hodgkin's and non-Hodgkins lymphoma, mycosis fungoides, histiocytosis, and Kaposi's sarcoma. |
| DB00541 | Vincristine | A vinca alkaloid used to treat acute leukemia, malignant lymphoma, Hodgkin's disease, acute erythraemia, and acute panmyelosis. |